• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于光动力免疫疗法的稳定有机自由基光敏剂的微调

Fine-tuning of stable organic free-radical photosensitizers for photodynamic immunotherapy.

作者信息

Wang Xiang, Shi Gaona, Wei Rao, Li Meng, Zhang Qingyang, Zhang Tiantai, Chen Chuan-Feng, Hu Hai-Yu

机构信息

State Key Laboratory of Bioactive Substances and Function of Natural Medicine, Institute of Materia Medica, Chinese Academy of Medical Sciences, Peking Union Medical College Beijing 100050 China

Beijing National Laboratory for Molecular Sciences, CAS Key Laboratory of Molecular Recognition and Function, Institute of Chemistry, Chinese Academy of Sciences Beijing 100190 China

出版信息

Chem Sci. 2024 Apr 3;15(17):6421-6431. doi: 10.1039/d3sc06826a. eCollection 2024 May 1.

DOI:10.1039/d3sc06826a
PMID:38699264
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11062115/
Abstract

Photodynamic immunotherapy (PDI) is an innovative approach to cancer treatment that utilizes photodynamic therapy (PDT) and photosensitizers (PSs) to induce immunogenic cell death (ICD). However, currently most commonly used PSs have restricted capabilities to generate reactive oxygen species (ROS) a type-II mechanism under hypoxic environments, which limits their effectiveness in PDI. To overcome this, we propose a novel approach for constructing oxygen independent PSs based on stable organic free-radical molecules. By fine-tuning the characteristics of tris(2,4,6-trichlorophenyl)-methyl (TTM) radicals through the incorporation of electron-donating moieties, we successfully found that TTMIndoOMe could produce substantial amounts of ROS even in hypoxic environments. experiments showed that TTMIndoOMe could effectively produce O˙, kill tumor cells and trigger ICD. Moreover, experiments also demonstrated that TTMIndoOMe could further trigger anti-tumor immune response and exhibit a superior therapeutic effect compared with PDT alone. Our study offers a promising approach towards the development of next-generation PSs functioning efficiently even under hypoxic conditions and also paves the way for the creation of more effective PSs for PDI.

摘要

光动力免疫疗法(PDI)是一种创新的癌症治疗方法,它利用光动力疗法(PDT)和光敏剂(PSs)诱导免疫原性细胞死亡(ICD)。然而,目前最常用的PSs在缺氧环境下产生活性氧(ROS)(一种II型机制)的能力有限,这限制了它们在PDI中的有效性。为了克服这一问题,我们提出了一种基于稳定有机自由基分子构建不依赖氧气的PSs的新方法。通过引入供电子基团来微调三(2,4,6-三氯苯基)-甲基(TTM)自由基的特性,我们成功发现TTMIndoOMe即使在缺氧环境中也能产生大量ROS。实验表明,TTMIndoOMe能有效产生O˙,杀死肿瘤细胞并触发ICD。此外,实验还证明TTMIndoOMe能进一步触发抗肿瘤免疫反应,与单独的PDT相比具有更好的治疗效果。我们的研究为开发即使在缺氧条件下也能有效发挥作用的下一代PSs提供了一种有前景的方法,也为创建更有效的PDI用PSs铺平了道路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d179/11062115/54574f6cc3dc/d3sc06826a-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d179/11062115/10835f850141/d3sc06826a-s1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d179/11062115/0ec3bd2b90e3/d3sc06826a-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d179/11062115/6b359bd4f3f6/d3sc06826a-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d179/11062115/e6b6c8431547/d3sc06826a-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d179/11062115/556f9959a012/d3sc06826a-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d179/11062115/d7045c0c1c65/d3sc06826a-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d179/11062115/54574f6cc3dc/d3sc06826a-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d179/11062115/10835f850141/d3sc06826a-s1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d179/11062115/0ec3bd2b90e3/d3sc06826a-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d179/11062115/6b359bd4f3f6/d3sc06826a-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d179/11062115/e6b6c8431547/d3sc06826a-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d179/11062115/556f9959a012/d3sc06826a-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d179/11062115/d7045c0c1c65/d3sc06826a-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d179/11062115/54574f6cc3dc/d3sc06826a-f6.jpg

相似文献

1
Fine-tuning of stable organic free-radical photosensitizers for photodynamic immunotherapy.用于光动力免疫疗法的稳定有机自由基光敏剂的微调
Chem Sci. 2024 Apr 3;15(17):6421-6431. doi: 10.1039/d3sc06826a. eCollection 2024 May 1.
2
Recent advances in type I organic photosensitizers for efficient photodynamic therapy for overcoming tumor hypoxia.近年来,I 型有机光敏剂在克服肿瘤缺氧的高效光动力治疗方面取得了进展。
J Mater Chem B. 2023 May 31;11(21):4600-4618. doi: 10.1039/d3tb00545c.
3
Molecular Engineering of Pure Superoxide Radical Photogenerator for Hypoxia-Tolerant Tumor Theranostics.纯超氧自由基光发生器的分子工程用于耐缺氧肿瘤治疗学。
Small. 2024 Nov;20(47):e2405164. doi: 10.1002/smll.202405164. Epub 2024 Aug 24.
4
Photodynamic Therapeutic Effect of Nanostructured Metal Sulfide Photosensitizers on Cancer Treatment.纳米结构金属硫化物光敏剂在癌症治疗中的光动力治疗效果
Nanoscale Res Lett. 2022 Mar 8;17(1):33. doi: 10.1186/s11671-022-03674-8.
5
Selenium-Containing Type-I Organic Photosensitizers with Dual Reactive Oxygen Species of Superoxide and Hydroxyl Radicals as Switch-Hitter for Photodynamic Therapy.含硒的 I 型有机光增敏剂,具有超氧阴离子和羟自由基两种活性氧物种,是光动力治疗的两用选手。
Adv Sci (Weinh). 2023 Aug;10(24):e2301902. doi: 10.1002/advs.202301902. Epub 2023 Jun 25.
6
ROS-responsive self-activatable photosensitizing agent for photodynamic-immunotherapy of cancer.ROS 响应型自激活光动力免疫治疗光敏剂用于癌症治疗。
Acta Biomater. 2023 Jul 1;164:511-521. doi: 10.1016/j.actbio.2023.03.038. Epub 2023 Mar 31.
7
Type I photosensitizers based on phosphindole oxide for photodynamic therapy: apoptosis and autophagy induced by endoplasmic reticulum stress.基于氧化膦吲哚的I型光动力治疗光敏剂:内质网应激诱导的细胞凋亡和自噬
Chem Sci. 2020 Mar 2;11(13):3405-3417. doi: 10.1039/d0sc00785d. eCollection 2020 Apr 7.
8
An acceptor-shielding strategy of photosensitizers for enhancing the generation efficiency of type I reactive oxygen species and the related photodynamic immunotherapy.一种用于提高I型活性氧生成效率及相关光动力免疫疗法的光敏剂受体屏蔽策略
Nanoscale. 2022 Oct 6;14(38):14064-14072. doi: 10.1039/d2nr02273g.
9
Vacancy Engineering to Regulate Photocatalytic Activity of Polymer Photosensitizers for Amplifying Photodynamic Therapy against Hypoxic Tumors.空位工程调控聚合物光敏剂的光催化活性以增强乏氧肿瘤的光动力治疗。
ACS Appl Mater Interfaces. 2021 Aug 25;13(33):39055-39065. doi: 10.1021/acsami.1c09466. Epub 2021 Aug 15.
10
Regulating the bacterial oxygen microenvironment via a perfluorocarbon-conjugated bacteriochlorin for enhanced photodynamic antibacterial efficacy.通过氟化碳共轭细菌叶绿素来调节细菌的氧微环境,以增强光动力抗菌疗效。
Acta Biomater. 2022 Apr 1;142:242-252. doi: 10.1016/j.actbio.2022.02.013. Epub 2022 Feb 17.

引用本文的文献

1
Dual-Activatable Nano-Immunomodulator for NIR-II Fluorescence Imaging-Guided Precision Cancer Photodynamic Immunotherapy.用于近红外二区荧光成像引导的精准癌症光动力免疫治疗的双激活纳米免疫调节剂
Adv Sci (Weinh). 2024 Dec;11(45):e2409833. doi: 10.1002/advs.202409833. Epub 2024 Oct 14.

本文引用的文献

1
A telluroviologen-anchored tetraphenylporphyrin as sonosensitizer for periodontitis sonodynamic therapy.碲杂环戊二烯 anchored 四苯基卟啉作为牙周炎声动力学治疗的超声敏化剂。
Biomaterials. 2024 Jan;304:122407. doi: 10.1016/j.biomaterials.2023.122407. Epub 2023 Nov 23.
2
The role of the light source in antimicrobial photodynamic therapy.光源在光动力抗菌疗法中的作用。
Chem Soc Rev. 2023 Mar 6;52(5):1697-1722. doi: 10.1039/d0cs01051k.
3
Smart Nanosensitizers for Activatable Sono-Photodynamic Immunotherapy of Tumors by Redox-Controlled Disassembly.
用于通过氧化还原控制解离实现肿瘤可激活声动力免疫治疗的智能纳米敏化剂
Angew Chem Int Ed Engl. 2023 Mar 1;62(10):e202217055. doi: 10.1002/anie.202217055. Epub 2023 Jan 31.
4
Towards Efficient and Stable Donor-Acceptor Luminescent Radicals.朝着高效稳定的给体-受体发光自由基迈进。
Adv Mater. 2023 Feb;35(6):e2208190. doi: 10.1002/adma.202208190. Epub 2022 Dec 16.
5
From Low to No O-Dependent Hypoxia Photodynamic Therapy (hPDT): A New Perspective.从低氧到无 O-依赖缺氧光动力疗法(hPDT):新视角。
Acc Chem Res. 2022 Nov 15;55(22):3253-3264. doi: 10.1021/acs.accounts.2c00531. Epub 2022 Nov 2.
6
Supramolecular photodynamic agents for simultaneous oxidation of NADH and generation of superoxide radical.用于同时氧化 NADH 和生成超氧自由基的超分子光动力剂。
Nat Commun. 2022 Oct 19;13(1):6179. doi: 10.1038/s41467-022-33924-3.
7
Near-infrared (NIR) fluorescence-emitting small organic molecules for cancer imaging and therapy.近红外(NIR)荧光小分子用于癌症成像和治疗。
Chem Soc Rev. 2022 Oct 31;51(21):8957-9008. doi: 10.1039/d2cs00722c.
8
A tailored and red-emissive type I photosensitizer to potentiate photodynamic immunotherapy.一种定制的红光发射 I 型光敏剂,以增强光动力免疫治疗。
J Mater Chem B. 2022 Oct 12;10(39):8003-8012. doi: 10.1039/d2tb01578a.
9
Reactive oxygen species-responsive and Raman-traceable hydrogel combining photodynamic and immune therapy for postsurgical cancer treatment.用于术后癌症治疗的活性氧响应和拉曼可追踪水凝胶,结合光动力和免疫治疗。
Nat Commun. 2022 Aug 5;13(1):4553. doi: 10.1038/s41467-022-32160-z.
10
Progress in advanced nanotherapeutics for enhanced photodynamic immunotherapy of tumor.先进纳米治疗在增强肿瘤光动力免疫治疗中的进展。
Theranostics. 2022 Jul 4;12(12):5272-5298. doi: 10.7150/thno.73566. eCollection 2022.